Dr. Marco Emgenbroich, LTS Lohmann Therapy Systems
Dr. Marco Emgenbroich
Corporate Vice President Head of Pharmaceutical Development
LTS Lohmann Therapy Systems

Dr. Marco Emgenbroich studied chemistry at the Heinrich-Heine University of Düsseldorf in Germany. He then joined a graduate school program on molecular physiology for PhD candidates and in early 2003 received his doctorate degree in organic and macromolecular chemistry. After a postdoctoral fellowship in the biomedical applications of polymer matrices, Marco began his industrial career in the biotech field, where he worked on delivery of peptides and protein drug for parenteral applications. Early in 2011 he joined the R&D department of LTS Lohmann Therapy Systems in Germany, where he was responsible for the late stage development program and global launch of the Neupro patch. Since 2015, Marco has been responsible for pharmaceutical development teams working on collaboration projects in the area of transdermal therapeutic systems and oral thin films.